Zhejiang Gongdong Medical Technology Future Growth
Future criteria checks 5/6
Zhejiang Gongdong Medical Technology is forecast to grow earnings and revenue by 31.9% and 24.3% per annum respectively. EPS is expected to grow by 31.7% per annum. Return on equity is forecast to be 16.4% in 3 years.
Key information
31.9%
Earnings growth rate
31.7%
EPS growth rate
| Medical Equipment earnings growth | 23.5% |
| Revenue growth rate | 24.3% |
| Future return on equity | 16.4% |
| Analyst coverage | Low |
| Last updated | 11 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2,051 | 374 | 491 | 537 | 2 |
| 12/31/2025 | 1,700 | 311 | 364 | 422 | 2 |
| 12/31/2024 | 1,379 | 246 | 196 | 410 | 2 |
| 6/30/2024 | 1,071 | 143 | 88 | 186 | N/A |
| 3/31/2024 | 1,021 | 125 | 89 | 188 | N/A |
| 12/31/2023 | 975 | 109 | 64 | 185 | N/A |
| 9/30/2023 | 1,002 | 106 | 112 | 189 | N/A |
| 6/30/2023 | 1,128 | 176 | 136 | 248 | N/A |
| 3/31/2023 | 1,347 | 260 | 143 | 268 | N/A |
| 12/31/2022 | 1,469 | 326 | 111 | 283 | N/A |
| 9/30/2022 | 1,527 | 367 | 138 | 382 | N/A |
| 6/30/2022 | 1,417 | 344 | 3 | 285 | N/A |
| 3/31/2022 | 1,280 | 327 | 32 | 350 | N/A |
| 12/31/2021 | 1,194 | 311 | 97 | 373 | N/A |
| 9/30/2021 | 1,088 | 319 | 326 | 269 | N/A |
| 6/30/2021 | 1,068 | 313 | 208 | 379 | N/A |
| 3/31/2021 | 989 | 281 | 177 | 304 | N/A |
| 12/31/2020 | 830 | 226 | 134 | 242 | N/A |
| 9/30/2020 | 744 | 191 | -160 | 220 | N/A |
| 6/30/2020 | 638 | 155 | 58 | 142 | N/A |
| 3/31/2020 | 529 | 113 | 20 | 113 | N/A |
| 12/31/2019 | 553 | 114 | 20 | 122 | N/A |
| 12/31/2018 | 483 | 86 | 67 | 102 | N/A |
| 12/31/2017 | 431 | 54 | N/A | 86 | N/A |
| 12/31/2016 | 371 | 61 | N/A | 86 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 605369's forecast earnings growth (31.9% per year) is above the savings rate (2.9%).
Earnings vs Market: 605369's earnings (31.9% per year) are forecast to grow faster than the CN market (23% per year).
High Growth Earnings: 605369's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 605369's revenue (24.3% per year) is forecast to grow faster than the CN market (13.1% per year).
High Growth Revenue: 605369's revenue (24.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 605369's Return on Equity is forecast to be low in 3 years time (16.4%).